![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 1.82% | 14.00 | 13.50 | 14.50 | 14.625 | 13.75 | 13.75 | 1,091,536 | 16:29:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 2.19M | -20.13M | -0.0773 | -1.81 | 36.48M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/1/2024 16:03 | North of the share price following fda! | ![]() fhmktg | |
18/1/2024 16:02 | Could we get both feet in the 20's before the close | ![]() rb1947 | |
18/1/2024 15:54 | Any offer would surely have to be well north of the last placing price of 80p | ![]() rb1947 | |
18/1/2024 15:50 | Imho Angles tech will go cheaply to the states. Every promising UK tech goes state side. | ![]() john henry | |
18/1/2024 15:37 | Thanks, would be nice to get a positive update on the front this month especially with the conference in USA coming up in 2 weeks and the investor meeting on Feb 6thAtb | ![]() rb1947 | |
18/1/2024 15:34 | Just watched the presentation - thought the comment at the end about possible knockout offers was honest and showed a good awareness- prime objective is to ensure any offer in part or full would reflect the 'true value' rather than being opportunistic. Would be interesting to know if they have already had approaches! RB- initial read out for prostate was slated as 'around year end 23' | ![]() fhmktg | |
18/1/2024 15:23 | Do we expect the prostrate study results p be out in Q1?Tia | ![]() rb1947 | |
18/1/2024 14:54 | Thanks Mr K. 120 tests a day from one technician would require 30 machines running (assuming 8hr shift and 4 per day per machine) | ![]() waterloo01 | |
18/1/2024 14:28 | With regards to recent comments on how long a Parsortix test takes to carry out, see below link from the Parsortix Instructions for Use manual. It appears to take +/1 15minutes to run a test through the machine, followed by a clean cycle of 45 minutes, followed by a further 15minute settling period prior to CTC harvesting & counting. Thats another Bulletin Board myth put to bed...... Therefore in an 8 hour shift, assuming 6 Hours of productive work 1 Lab operator could carry out 120 Parsortix tests per shift. 120 test x $1000 Minimum = $120k per day / $600k per week / $2.4m per month / $28.2m per annum assuming 47 week production. 120 test x $3000 Mean = $360k per day / $1.8m per week / $7.2m per month / $84.6m per annum assuming 47 week production. 120 test x $5000 High = $600k per day / $3m per week / $2.4m per month / $141m per annum assuming 47 week production. From yesterdays presentation AN also stated that 1 Lab Operator could process 20 machines simultaneously. Mr K. | ![]() mrkeysersoze | |
18/1/2024 14:07 | Righty if you do read this and want to buy Agl and it's already up 1-2p back off, as soon as one sale hits there's about 10-15 people seem to panic sell and take the price back down. It's just going through runs of all buys v all sales so try and buy after a long run of sales and save yourself 1-2p | ![]() dave4545 | |
18/1/2024 13:09 | Berenberg note out, target 70p | ![]() muffster | |
18/1/2024 12:06 | Lots locked out today now having to pay 2p higher to get back in 22p again today ? | ![]() dave4545 | |
18/1/2024 12:03 | Shhhhh! Don't wake the sellers..... Looks like they've overslept. | ![]() boris cobaka | |
18/1/2024 10:36 | Are you glad you sold out with the other sheep this morning at 17.6p levels Now 19.1p bid | ![]() dave4545 | |
18/1/2024 10:09 | Cracking work by the MMs tbh. Suck in the shorters early doors, get some stock to sell then the buying starts and accelerates as they buy back. Nice to see since usually the other way round! | ![]() gspanner | |
18/1/2024 09:23 | This is the bottom and will bounce mid 20s before weekend | ![]() kirk 6 | |
18/1/2024 09:22 | Just like FDA approval was an if but and maybe for the doom mongers. | ![]() jelenko | |
18/1/2024 08:24 | Unfortunately as ever with Angle to many IF BUTs and MAYBEs | ![]() john henry | |
17/1/2024 21:39 | Were you watching the same presentation as me? Dont think so bones squared! Thank you Sole Trader - I think you teased out the crucial detail. | ![]() gspanner | |
17/1/2024 20:22 | Anyone else find the ref to EISAI interesting? 80 ACTIVE oncology trials 60,000 Participants 3 potential Timelines for SAMPLING patient blood (before, during, after) AGL state sliding scale charge for processing blood samples - range from £1k to £5k (say average at £3k ?)AM I RIGHT WITH THIS??? 180,000 samples x £3k sample charge = £540M of potential opportunity for AGL with just ONE large Pharma customer? -Re Distributors: Good to see 100+ boots on the ground - fully trained staff (establishing global presence) Nicely Incentivised at 30% commission re sales-HOCKEY STICK revenue referenced once again with: 2024 revenues expected to AT LEAST treble.-Re the Parsortix Machine itself: Easy to Use One (1) of AGLs technicians is capable of running twenty (20) machines simultaneously - impressive?-Re ILLUMINA: generating $4B in sequencing revenues approx 3000 illumina systems in current use Financially - Plugin the 'Parsortix Inside' technology with above - fruitful partnership?-Re Ovarian: AGL currently using in house molecular platform Want to MOVE it across to Illumina and ThermoFisher systems. WHY?-Re DDR Inhibitors Summit: AGL attending DDR inhibitor development is evolving rapidly, marked by the continuous emergence of new targets. ASTRAZENECA and MERCK reaffirm their commitment to DDR inhibitors, yet more pharmaceutical companies like ROCHE and GILEAD are diving into this therapeutic strategy; biotech companies like ARTIOS and IDEAYA remain dedicated todelivering safe and effective treatments to patients. https://ddr-inhibito | 5oletrader | |
17/1/2024 19:03 | Excellent presentation and its just a matter of time before big things happen Some patience is required. | ![]() jakes114 | |
17/1/2024 15:38 | Key part of presentation https://x.com/reddit | ![]() stevehuges | |
17/1/2024 15:30 | Just watched the presentation. Must say I'm very impressed with what they've achieved and where the potential lies here. It looks like they've got a vision and plan in place and the tech is second to none. It's going to do well. Share price will be many multiples of current price, just need some patience. | ![]() rajraj b |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions